Saudi Arabia to become destination for pharmaceutical sector: Fitch Solutions
RIYADH: Saudi Arabia’s business landscape is expected to see a surge in investments from the pharmaceutical sector, with growing demand for healthcare services and increasing fundraising activity in the industry, according to Fitch Solutions, the research arm of US-based Fitch Ratings.…#saudiarabias #fitchsolutions #fitchratings #kingdom #vision2030 #novartis #pfizer #sanofi #merck #saudiarabia (Source: Reuters: Health)
Source: Reuters: Health - July 13, 2023 Category: Consumer Health News Source Type: news
Big Pharma Vs. Washington
As I mentioned on my last Blog Post, blood clot drug Eliquis, sold by both Bristol Myers Squibb and Pfizer (PFE), is likely to face price controls under the Inflation Reduction Act (IRA). Recall that Bristol and Merck have each sued Uncle Sam over a Medicare price renegotiation program in the IRA…#eliquis #bristolmyerssquibb #pfe #bristol #merck #unclesam #medicare #pfizer #bristolmyers #noncovid (Source: Reuters: Health)
Source: Reuters: Health - June 29, 2023 Category: Consumer Health News Source Type: news
Merck Accused of Downplaying Evidence of Drug ’s Brain Impact Merck Accused of Downplaying Evidence of Drug ’s Brain Impact
An early magazine advertisement for Merck ’s breakthrough asthma and allergy medicine, Singulair, featured a happy child, hanging upside-down from a tree.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 27, 2023 Category: Allergy & Immunology Tags: Pediatrics News Source Type: news
Analysis-Companies' derivative bets to save on US debt costs turn riskier
A type of derivative trade that became popular with companies over the past year to save on interest costs is seeing demand slow, with risk increasing that the bets could backfire as the Federal Reserve nears the end of its policy tightening cycle. The so-called pre-issuance hedges are derivative…#federalreserve #lowe #merck #treasury #richardwolff #societegenerale #scottshulte #citigroup #amoldhargalkar #chathamfinancial (Source: Reuters: Health)
Source: Reuters: Health - June 27, 2023 Category: Consumer Health News Source Type: news
Merck downplayed severe psychological side-effects of its blockbuster children's asthma drug
A slew of lawsuits against Merck alleges the company covered up links between its asthma drug Singulair and severe effects on mental health, even causing suicide in at least 82 cases. (Source: the Mail online | Health)
Source: the Mail online | Health - June 26, 2023 Category: Consumer Health News Source Type: news
Phase 3 Keytruda, Chemotherapy Mesothelioma Trial Shows Promising Results
Pharmaceutical company Merck says use of its immunotherapy drug Keytruda in conjunction with chemotherapy increases the survival rate for people with advanced pleural mesothelioma, according to the latest results of a phase 3 clinical trial.
The results were announced in June at the annual meeting of the American Society of Clinical Oncology. They showed Merck’s use of the anti-PD-1 treatment combined with chemotherapy reduced the patient’s risk of death by 21%.
Clinical trial results of the multimodal treatment using immunotherapy and chemo also showed a median overall survival of 17.3 months in comparison...
Source: Asbestos and Mesothelioma News - June 26, 2023 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Mesothelioma Source Type: news
Today's Logistics Report: Supply Chain Silos; Buying More Warehouses; Aircraft on Demand
More Western companies are trying to lower their risks from growing tensions between Washington and Beijing by effectively placing their China businesses in silos. The strategies by companies including automaker Volkswagen and Japanese bathroom product manufacturer Lixil go as far as forging…#beijing #volkswagen #wsj #elaineyu #yokokubota #merck #blackstone #petergrant #prologis #tiktok (Source: Reuters: Health)
Source: Reuters: Health - June 26, 2023 Category: Consumer Health News Source Type: news
Scientists Say They ’ve Reached ‘Turning Point’ in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
“We’re getting something to work. Now we need to get it to work better,” said Dr. James Gulley, who help...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
Scientists Say They ’ve Reached Turning Point in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
More from TIME
[video id=W5jcvwLu autostart="viewable"]
“We’re getting something to work. Now we need to get...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
Big Pharma Vs. Washington
Warren Buffett states, “Uncertainty is the friend of the buyer of long-term values,” and Washington represents a big question mark these days for the pharmaceutical sector. After all, news broke a week ago that Bristol Myers Squibb had sued Uncle Sam over a Medicare price renegotiation program in…#warrenbuffett #bristolmyerssquibb #unclesam #medicare #merckco #bristolmyers #merck #constitution #fifthamendment #ira (Source: Reuters: Health)
Source: Reuters: Health - June 23, 2023 Category: Consumer Health News Source Type: news
Pfizer's Talzenna snags broader prostate cancer nod than AstraZeneca and Merck's rival PARP med
The PARP inhibitor class is welcoming its second FDA approval in prostate cancer in the span of several weeks. The new approval, for Pfizer, is broader than the first but still limited. | The PARP inhibitor class is welcoming its second FDA approval in prostate cancer in the span of several weeks.…#parp #fda #pfizer (Source: Reuters: Health)
Source: Reuters: Health - June 21, 2023 Category: Consumer Health News Source Type: news
Eli Lilly Acquires Biotech Firm Dice
The pharmaceutical business isn’t all about weight-loss drugs. Drug-making giant Eli Lilly announced on Tuesday it agreed to buy Dice, a firm that specializes in making oral treatments for autoimmune diseases, for $2.4 billion, representing a 40% premium on Dice’s shares. Skin In The Game Eli…#elililly #dice #skiningameelililly #merck #argenx #rheumatoid #crohn #taltz #novonordisk #mounjaro (Source: Reuters: Health)
Source: Reuters: Health - June 21, 2023 Category: Consumer Health News Source Type: news
China Pharma Billionaire Adds To Fortune Following Genrix Listing In Shanghai
Chinese pharmaceutical industry billionaire Jiang Rensheng added to his fortune today with the start of trade at the Shanghai Stock Exchange by Chongqing Genrix Biopharmaceutical, a supplier of antibody drugs. Jiang’s estimated fortune of $9.3 billion on the Forbes Real-Time Billionaires List…#jiangrensheng #shenzhen #zhiruiinvestment #genrix #merck #hpv #diplomaticdriveby #conflictscontinue #arab #beijing (Source: Reuters: Health)
Source: Reuters: Health - June 20, 2023 Category: Consumer Health News Source Type: news
Inflation Reduction Act foes race to repeal climate, drug pricing programs
Yet the law stopped short of Biden’s original, roughly $2 trillion re-envisioning of the role of government in Americans’ lives, after Democrats failed to overcome their own internal fissures — and unanimous Republican objections. Lawmakers also faced an onslaught of lobbying: The nation’s largest…#democrats #opensecrets #merck #abbvie #elililly #medicare #barackobama #affordablecareact #republicans #kevinmccarthy (Source: Reuters: Health)
Source: Reuters: Health - June 18, 2023 Category: Consumer Health News Source Type: news
Bristol Myers Squibb joins in on challenging Medicare drug price negotiation program
U.S. pharmaceutical company Bristol Myers Squibb (BMS) on Friday became the latest organization to file a legal challenge against the the Medicare drug price negotiation program established by the Inflation Reduction Act (IRA). This suit echoes the complaints filed by Merck & Co. and the Chamber…#bristolmyerssquibb #bms #medicare #merckco #chamberofcommerce #fifthamendments #ira #firstamendment #medicaid #karinejeanpierre (Source: Reuters: Health)
Source: Reuters: Health - June 16, 2023 Category: Consumer Health News Source Type: news
